Physician

Esther Hwang, M.D.

According to 2025 Medicare claims, Esther Hwang, M.D. (NPI: 1215035670) practices rheumatology in the Portland-Vancouver-Hillsboro, OR-WA market, with the plurality of this provider's patient population coming from Clark, WA. This provider's primary affiliated billing organization is THE VANCOUVER CLINIC INC PS (NPI: 1992759427; TIN: 910851599) and primary practice location at 98664-1913. Hwang is affiliated with the PSW ACO (ACO ID: A5323) and Humana Direct Contracting Entity, Inc. (ACO ID: D0203), participating under both the MSSP and REACH models.

Hwang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 178 traditional Medicare patients, billed 6,924 HCPCS/CPT codes, and received $105,307 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,597 prescription claims across 260 beneficiaries totaling $1,239,595 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2019 DME data shows 12 claims. Open Payments data shows 2 records totaling $7,625. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $47,818 to $105,307. Similarly, Part D prescription costs have moved sharply higher in recent years, from $319,235 to $1,239,595. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$161K$322K2015 Medicare payment: $47,818 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $39,035 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $39,205 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $39,789 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $46,745 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $72,515 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $321,703 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $246,713 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $96,524 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $105,307 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151791,759$47,818
20161731,766$39,035
20171721,744$39,205
20181811,954$39,789
20191732,140$46,745
20201903,023$72,515
202120026,219$321,703
202221417,404$246,713
20231805,018$96,524
20241786,924$105,307

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$620K$1.2M2015 Drug cost: $319,235 (USD; Tot_Drug_Cst)2016 Drug cost: $403,720 (USD; Tot_Drug_Cst)2017 Drug cost: $581,681 (USD; Tot_Drug_Cst)2018 Drug cost: $595,741 (USD; Tot_Drug_Cst)2019 Drug cost: $724,316 (USD; Tot_Drug_Cst)2020 Drug cost: $601,518 (USD; Tot_Drug_Cst)2021 Drug cost: $582,764 (USD; Tot_Drug_Cst)2022 Drug cost: $1,042,799 (USD; Tot_Drug_Cst)2023 Drug cost: $1,215,654 (USD; Tot_Drug_Cst)2024 Drug cost: $1,239,595 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151711,092$319,235
20161601,126$403,720
2017165942$581,681
2018175954$595,741
20192071,087$724,316
20202651,329$601,518
20212301,424$582,764
20222361,419$1,042,799
20232791,506$1,215,654
20242601,597$1,239,595

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$57$1152019 Medicare payment: $115 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191112$115
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more138255$89
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's126194$12
80053Blood test, comprehensive group of blood chemicals98253$10
36415Insertion of needle into vein for collection of blood sample113262$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count87216$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab621,736$424,863
Enbrel SureclickEtanercept31980$257,366
Cosentyx Sensoready PenSecukinumab11336$144,635
Humira PenAdalimumab12496$124,623
Hydroxychloroquine SulfateHydroxychloroquine Sulfate26721,660$10,358

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.0$0N/R
Research PaymentsReported research-related payment or transfer-of-value amount.2$7,625Eli Lilly and Company
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Esther Hwang, M.D.?

Tedicare shows public-source Medicare data for Esther Hwang, M.D. (NPI 1215035670), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Esther Hwang, M.D. have ACO affiliation data?

Esther Hwang, M.D. is shown with ACO affiliation data for PSW ACO (MSSP, ACO ID A5323) and Humana Direct Contracting Entity, Inc. (REACH, ACO ID D0203).

What billing organization is linked to Esther Hwang, M.D.?

Esther Hwang, M.D. is linked to THE VANCOUVER CLINIC INC PS (billing NPI 1992759427) in the available physician profile data.

Does Esther Hwang, M.D. have Open Payments data?

Esther Hwang, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.